SHARONE SABO: Open Payments
NPI 1710440615 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 47 payments from 13 companies in 2025. Trend: 2023 $298 · 2024 $932 · 2025 $1,020
Food & beverage: $920Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $277 |
| Janssen Biotech, Inc. | 9 | $217 |
| E.R. Squibb & Sons, L.L.C. | 13 | $185 |
| Lilly USA, LLC | 4 | $81 |
| Incyte Corporation | 3 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Botanix SB Inc | 2 | $40 |
| Organon LLC | 1 | $25 |
| Organogenesis Inc. | 1 | $23 |
| Almirall LLC | 1 | $20 |
Products named: TREMFYA, Sotyktu, DUPIXENT, TALTZ, OPZELURA, SOFDRA, AFFINITY, EBGLYSS.
Industry payments across NY — which companies pay providers there.
